Dr Patrick Lewis (IoN Department of Molecular Neuroscience) had been awarded a Parkinson’s UK career development fellowship to study the molecular impact of mutations in LRRK2, which constitute the most common genetic cause of Parkinson’s disease.
[image reference is broken]The research, funded for £250,000 over the next three years, will provide an insight into the underlying mechanisms operating in Parkinson’s disease.
Dr Lewis commented that “LRRK2 is one of the most promising drug targets that has been revealed to us by studying the molecular genetics of Parkinson’s disease. This proposal will provide invaluable information as to what aspects of the biology of LRRK2 we need to target in order to counteract the deleterious impact that mutations in this protein can cause”.
He will be discussing his research at the upcoming Parkinson’s UK conference to be held in York at the end of October.
read more >> Parkinson’s UK